Our research focuses on understanding the immune system in order to develop bio-instructive materials that stimulate specific immune responses. We aim to control immune cell migration to synthetic microenvironments that are engineered to program and expand regulatory immune cells as a therapeutic tool for inflammatory disease. We employ these technologies in animal disease models with the long-term goal of developing translational therapies for atherosclerosis, diabetes, and cancer.